The Efficacy and Safety of Atorva® 20mg Versus Lipitor® 20mg
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 376 participants.
Also called NCT01624207
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 376 participants
- Registry
-
NCT01624207
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT01624207. Randomized; no masking; primary purpose treatment. Start 2010-03 (registry gives no type); primary completion 2011-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Efficacy and Safety of Atorva® 20mg Versus Lipitor® 20mg
- Condition
- Hypercholesterolemia
- Intervention (Drug)
- generic formulation of atorvastatin (Atorva®)
- Intervention (Drug)
- branded formulation of atorvastatin (Lipitor®)
- Lead sponsor
- Seoul National University Hospital
- Collaborator
- Yuhan corp., Seoul, Korea
Record details
- Record id
cardio:ct-nct01624207- Content hash
988083cd14e70001f34345f66a1c570e45ce56f179749df45203065d64a00bd2